You are here

China

Celgene-partnered Antengene preps new China deals as $21M round lands

Celgene-partnered Antengene preps new China deals as $21M round lands

Endpoints

Flag link:

10 Reasons Illumina's Momentum Is Just Cranking Up

10 Reasons Illumina's Momentum Is Just Cranking Up

Motley Fool

Flag link:

Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment

Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment

Endpoints

Sarepta Therapeutics

Duchenne Muscular Dystrophy

Flag link:

FDA lifts warning letter on Zimmer Biomet plant in China

FDA lifts warning letter on Zimmer Biomet plant in China

Mass Device

Flag link:

New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing

New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing

Endpoints

venture capital

Platelet BioGenesis

platelet manufacturing

Flag link:

Boehringer Ingelheim opens large manufacturing facility in China

Boehringer Ingelheim opens large manufacturing facility in China

BioPharma Dive

Boehringer Ingelheim

drug manufacturing

Flag link:

Chinese Regulators Set Procedures for Medical Device Expert Panel Meetings

Chinese Regulators Set Procedures for Medical Device Expert Panel Meetings

Emergo

Flag link:

Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus

Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus

Marketwatch

Bristol-Myers Squibb

Flag link:

China pharma poised for explosive growth, Novartis CEO says

China pharma poised for explosive growth, Novartis CEO says

Fierce Pharma

Flag link:

How US Drugmakers Profit From China's Biotech Boom

How US Drugmakers Profit From China's Biotech Boom

Investopedia

Flag link:

China FDA getting rid of medical device testing fees

China FDA getting rid of medical device testing fees

Mass Device

Flag link:

New guidelines to make China a more drug-friendly market

New guidelines to make China a more drug-friendly market

BioPharma Dive

Flag link:

AstraZeneca’s Lung Cancer Drug Secures China Approval

AstraZeneca’s Lung Cancer Drug Secures China Approval

Investopedia

non-small cell lung cancer

Flag link:

J&J CEO: US needs to focus on the long-term sustainability of health care

J&J CEO: US needs to focus on the long-term sustainability of health care

CNBC

healthcare reform

Flag link:

Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

Yahoo

rheumatoid arthritis

Flag link:

China Adds A Pharma Billionaire After Stock Soars

China Adds A Pharma Billionaire After Stock Soars

Forbes

Shenzhen Kangtai Biological

Flag link:

Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK

Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK

Endpoints

Flag link:

Inovio Inks $35M Chinese Drug License Deal

Inovio Inks $35M Chinese Drug License Deal

Investopedia

Flag link:

Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round

Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round

Endpoints

Flag link:

Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine

Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine

Forbes

personalized medicine

Flag link: